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Abstract: Listeria monocytogenes is a ubiquitous Gram-positive bacterium that is a major concern for
food business operators because of its pathogenicity and ability to form biofilms in food production
environments. Bacteriophages (phages) have been evaluated as biocontrol agents for L. monocytogenes
in a number of studies and, indeed, certain phages have been approved for use as anti-listerial
agents in food processing environments (ListShield and PhageGuard Listex). Endolysins are proteins
produced by phages in the host cell. They cleave the peptidoglycan cell wall, thus allowing release of
progeny phage into the environment. In this study, the amidase domain of the phage vB_LmoS_293
endolysin (293-amidase) was cloned and expressed in Escherichia. coli (E. coli). Muralytic activity at
different concentrations, pH and temperature values, lytic spectrum and activity against biofilms was
determined for the purified 293-amidase protein. The results showed activity on autoclaved cells at
three different temperatures (20 ◦C, 37 ◦C and 50 ◦C), with a wider specificity (L. monocytogenes 473
and 3099, a serotype 4b and serogroup 1/2b-3b-7, respectively) compared to the phage itself, which
targets only L. monocytogenes serotypes 4b and 4e. The protein also inhibits biofilm formation on
abiotic surfaces. These results show the potential of using recombinant antimicrobial proteins against
pathogens in the food production environment.
Keywords: listeriophage; endolysin; amidase
1. Introduction
In recent years, a number of studies have focused on finding novel biotechnological approaches
to prevent or remove L. monocytogenes biofilms [1–3]. Promising results have been obtained with the
utilisation of phages for L. monocytogenes removal [2,4–6]. Phages are bacterial viruses that can infect host
cells with high specificity. For L. monocytogenes biocontrol in the food industry, two products containing
phages are currently commercially available: Listex P100 (www.phageguard.com) and ListShield
(www.intralytix.com). Listex P100 contains the phage P100, a wide spectrum virulent listeriophage,
which has been proven to remove L. monocytogenes from foods and biofilms on food processing
environment surfaces [4,5,7–9]. ListShield is a cocktail of six listeriophages with demonstrated efficacy
against a wide spectrum of L. monocytogenes strains, both in foods and on biofilms [2,10–13]. Both phage
preparations have been approved by the US Food and Drug Administration (FDA) to be used during
food production and are under revision by the European Food Safety Authority [6].
From the perspective of using whole phages as biocontrol agents, virulent phages have been
regarded as much better options when compared to temperate phages [14]. The main reason for this is
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the possibility that bacterial cells might not be killed by the temperate phages because of their exclusion
by immunity mechanisms. Another reason is the ability of temperate phages to potentially transfer
unwanted genetic material to target hosts through lysogenic conversion [15]. Furthermore, phage
resistance can be developed in the bacteria [16]. For these reasons, the use of different phages and
phage-derived proteins are being investigated, including the use of phage endolysins [17].
Endolysins, or lysins, are enzymes encoded by the phage genome involved in the release of phage
progeny from the host cell. Their mode of action is through the cleavage of the peptidoglycan of
the host cell wall [18]. They usually act in conjunction with other phage-encoded proteins, known
as holins, a diverse group of small proteins that are involved in the formation of holes in the inner
membrane of the host cell, thus allowing the endolysin access to the peptidoglycan [19]. Based on
the presence of certain catalytic domains that determine which peptidoglycan bond is cleaved, phage
endolysins can be divided in five groups: muramidases, lytic transglycosylases, glucosaminidases,
amidases and endopeptidases [17]. Using recombinant endolysins as antimicrobial agents rather than
whole phages limits the possibility of development of bacterial resistance to the endolysin. Endolysins
recognize and cleave highly immutable targets in the cell wall—the peptidoglycan bonds. A mutation
at this level would most likely compromise the fitness of the bacterial cells [20]. The peptidoglycan is
located extracellularly, which reduces the number of mechanisms of resistance to endolysins when
applied from without. Many resistance mechanisms, such as the reduction of membrane permeability,
active efflux or inactivation by cytoplasmic enzymes, target antimicrobials acting inside the cell [21,22].
Some endolysins possess several catalytic domains that hydrolyse different bonds in the peptidoglycan,
which further reduce the chance of resistance development [23]. In addition to this, endolysins can be
used in combination with other endolysins or antimicrobials to further reduce the development of
resistance, showing synergistic effects in some cases [24–26]. Studies have already shown reduction of
L. monocytogenes cell numbers through the exogenous application of endolysins. For example, PlyP100,
the endolysin encoded by the listeriophage P100, has shown anti-listerial activity when applied to
drained curd during the production of fresh cheese, with only 0.5 log cfu/g reduction, but preventing
the growth of L. monocytogenes for more than 3 weeks [27]. The same endolysin, combined with
nisin, was applied during the production of queso fresco, showing a reduction in L. monocytogenes
numbers to under the detection limit. By contrast, the application of nisin alone showed very little
anti-listerial activity at the time of application, with consecutive regrowth of L. monocytogenes to levels
comparable to the untreated controls [28]. The endolysin LysZ5 of the phage FWLLm3 has shown more
than 5 log10 CFU mL−1 reduction of L. monocytogenes, L. innocua and L. welshimeri, without affecting
Staphylococcus. aureus or Enterococcus. faecalis in soya milk [29].
Endolysins against Gram-positive bacteria are usually formed by two or more domains, generally
including a catalytic domain and a cell wall binding domain. Further studies have shown the possibility
of using the catalytic domains of endolysins rather than the full-length protein as biocontrol agents.
In some cases, this resulted in a display of increased activity compared to the full length endolysin, as
shown by the activity of the cysteine- and histidine-dependent amidohydrolase/peptidase (CHAP)
domain of the staphylococcal phage endolysin LysK against strains of S. aureus [30]. In that study,
the CHAPK domain of LysK showed a broader lytic spectrum compared to the full endolysin and
lytic activity at different temperatures, pH and concentrations [30]. Recently, novel technologies
have been developed to increase the antimicrobial effect of endolysins, such as the production of
beads of polyhydroxyalkanoate (PHA) bionanoparticles (BNPs) displaying on the surface the protein
of interest [31], or microencapsulation, for example, into Poly(N-isopropylacrylamide) (PNIPAM)
nanoparticles, which allowed the release of CHAPk and lysostaphin when reaching a temperature of
37 ◦C [32].
Phage vB_LmoS_293 is a temperate member of the Siphoviridae family, which infects strains
of L. monocytogenes of the serotypes 4b and 4e [33]. Whole genome sequencing of this phage by
our group revealed its temperate nature [33]. The issues associated with employing temperate
phages for the purposes of biocontrol, described earlier in this paragraph, led to the pursuit of the
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endolysin of this phage as a potential biocontrol agent. The endolysin of phage vB_LmoS_293, an
N-acetylmuramoyl-l-alanine amidase, was chosen for further study. The aim of this work was to
produce a recombinant amidase, the catalytic domain of the vB_LmoS_293 endolysin, referred to as
293-amidase, and characterisation of its antimicrobial activity.
2. Materials and Methods
2.1. Bacterial Strains and Culture Conditions
The L. monocytogenes strains used for this study are detailed in Table 1. The listed strains were
isolated from two different projects and, depending on the project requirements, the serotype or the
serogroup were determined via agglutination test or PCR, respectively. All the strains were stored
at −20 ◦C and grown in Brain Heart Infusion (BHI, Oxoid Ltd., Basingstoke, UK) broth at 37 ◦C.
For the cloning and expression of the 293-amidase, E. coli TOP10 and E. coli BL21(DE3) were used,
respectively (Table 1). Transformed E. coli strains were stored at −80 ◦C and grown in Lysogeny Broth
(LB) containing 50 µg/mL kanamycin at 37 ◦C.
Table 1. Strains used in this study.
Strain ID Serotype/Serogroup Source
L. monocytogenes 473 * 4b Dairy industry
L. monocytogenes 777 * 1/2c Dairy industry
L. monocytogenes 2075 * 4b-4d-4e Mushroom industry
L. monocytogenes 2081 * 1/2a-3a Mushroom industry
L. monocytogenes 3099 * 1/2b-3b-7 Mushroom industry
L. innocua * Dairy industry
L. welshimeri * Dairy industry
L. ivanovii * Dairy industry
L. seeligeri * Mushroom industry
Bacillus. cereus * Dairy industry
Staphylococcus aureus S24 *
E. coli Top 10 Thermo Fisher Scientific
E. coli BL21 (DE3) Thermo Fisher Scientific
* These strains were provided by the collection of Teagasc, Moorepark, Fermoy, Co. Cork.
2.2. Bioinformatics Analysis
The listeriophage vB_LmoS_293 genome was previously annotated and deposited in the GeneBank
database with the Accession Number KP399678.1 [34]. The sequence of the open reading frame (ORF)
coding for the phage endolysin (GenBank accession number AJE28090.1) was analysed with the Basic
Local Alignment Search Tool (BLAST) against the Conserved Domains Database (CDD, [35]) for
identification of the amidase domain (293-amidase).
2.3. Amidase Cloning
Cloning of the 293-amidase was performed using the TOPO-TA cloning kit (Thermo Fisher Scientific,
Waltham, MA, USA), which includes the pCR®2.1-TOPO® vector, following the manufacturer’s instructions.
The pCri-8a was chosen as the expression vector for this study [36]. Phage DNA was extracted with the
phenol chloroform-isoamyl alcohol as described in Reference [34]. For cloning, the polymerase chain
reaction (PCR) and topoisomerase reaction were performed using the TOPO-TA cloning kit (Thermo Fisher
Scientific, USA) following the manufacturer’s instructions. The primers designed for the PCR reaction were:
Amidase_Fw_NcoI CGCGCCATGGCCATGTCAGTACTACAATATAATTATATCAATAAAAATCAATTT
and Amidase_Rv_HindIII CGCGCAAGCTTGCACCTTTCAATTTTGCATTG. The pCR®2.1-TOPO®-
293-amidase vector was transformed into chemically competent E. coli Top10 cells (Thermo Fisher
Scientific, Waltham, MA, USA), following the manufacturer’s instructions. The transformed cells were
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then plated on Lysogeny Broth (LB, Oxoid Ltd., UK) agar containing 50 µg/mL kanamycin and 40 µL
of 40 mg/mL X-gal (both supplied by Sigma, Arklow, Ireland) and incubated for 16 h at 37 ◦C. White
colonies were selected and screened for the presence of the insert with a colony PCR and grown for 16
h at 37 ◦C in LB broth with 50 µg/mL kanamycin, shaking at 250 rpm. Plasmid DNA was extracted
from each of the selected colonies using the QIAprep Spin mini-prep kit (Qiagen, Germany).
The 293-amidase was excised from the pCR®2.1-TOPO® vector by double digestion with the
endonucleases NcoI and HindIII (Thermo Fisher Scientific, USA), the pCri-8a plasmid was linearized
by double digestion with the same endonucleases and a ligation reaction (T4 DNA Ligase, New
England Biolabs, UK) was performed for 16 h at room temperature. Chemically competent E. coli
TOP10 cells were transformed with the ligation product, according to the manufacturer’s instructions.
The transformed cells were plated on LB agar containing 50 µg/mL kanamycin and incubated 16 h at
37 ◦C. Single colonies were grown in LB broth with 50 µg/mL kanamycin, shaking at 250 rpm and the
plasmids were recovered with a mini-prep kit and sequenced by Eurofins GATC, Germany. Chemically
competent E. coli BL21(DE3) (Thermo Fisher Scientific, USA) were transformed with the plasmids
containing the 293-amidase gene, following the manufacturer’s instructions and plated on LB agar
Petri dishes containing 50 µg/mL kanamycin and incubated for 16 h at 37 ◦C.
Sequences were analysed with the CLC Main Workbench 8 (https://www.qiagenbioinformatics.
com/products/clc-main-workbench/).
2.4. Protein Expression and Purification
One colony of E. coli BL21(DE3) transformed with pCri-8a-293-amidase was incubated for 16 h
in 10 mL of Terrific Broth (TB, 23.6 g/L yeast extract, 11.8 g/L tryptone, 9.4 g/L K2HPO4, 2.2 g/L
KH2PO4, 8 mL/L glycerol) with 50 µg/mL kanamycin (TB-K) at 37 ◦C, shaking at 250 rpm. A 3 L flask
containing 990 mL of TB-K was inoculated with 10 mL of a 16 h aerobic culture of E. coli BL21(DE3)
transformed with pCri-8a-293-amidase and incubated at 37 ◦C, shaking at 100 rpm. When the culture
reached 0.6 OD600, the cells were chilled on ice for 10 min and then induced by adding 1 mL isopropyl
β-D-1-thiogalactopyranoside (IPTG, Sigma, Ireland) 1 M (final concentration: 1 mM) and incubated
for a further 16 h at 16 ◦C. After incubation, the cells were chilled on ice for 10 min and harvested by
centrifugation at 2000× g for 30 min at 4 ◦C (Sorvall™ RC 6 Plus, Fisher Scientific, Canada). The cell
pellet was resuspended in 10 mL of lysis buffer (50 mM Tris, 300 mM NaCl, 10% glycerol) and frozen
until lysis was performed. The thawed cell pellet was lysed by sonication (MSE Soniprep 150, Fisher
Scientific, UK) with 5× medium frequency impulses for 10 s followed by 10 s of rest on ice. The lysate
was centrifuged in a top bench centrifuge at maximum speed for 30 min at 4 ◦C and the clarified
supernatant was filtered through a 0.22 µm syringe filter (Sarstedt, Germany). Subsequently, the filtrate
was incubated with 2 mL of Immobilised Metal Affinity Chromatography (IMAC) resin containing
nitrilotriacetic acid charged with Ni2+ (Ni-NTA) (Bio-Rad, USA) for 1 h on an orbital shaking platform.
The mix was transferred to a gravity chromatography column (Econo-Pac, Bio-Rad, USA) and affinity
chromatography purification was performed according to the manufacturer, using a running buffer
composed of 5 mM NaH2PO4, 30 mM Na2HPO4, 300 mM NaCl, 45 mM imidazole. After three
washing steps with running buffer, the 293-amidase was eluted in four fractions containing 145, 245,
345, and 545 mM imidazole, respectively. The fractions containing the purified 293-amidase were
pooled together and dialyzed for 16 h at 4 ◦C, using a dialysis membrane with a 10 kDa cut-off
10 kDa (VWR International Ltd., Ireland) in 1 L of phosphate buffer (NaH2PO4 5 mM, Na2HPO4
30 mM, NaCl 300 mM) to remove the imidazole. The purified protein was stored at −20 ◦C in 0.5 mL
aliquots. The concentration of the 293-amidase was estimated using the Pierce BCA protein assay
(Thermo Fisher Scientific, Waltham, MA, USA), following the microtiter plate protocol from the
manufacturer guidelines.
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2.5. In-Gel Digestion and Matrix-Assisted-Laser-Desorption/Ionization Time-of-Flight (MALDI-TOF)
Mass spectrometry (MS) grade Pierce Trypsin Protease (Rockford, IL, USA) was dissolved in
50 mM acetic acid to a final concentration of 10 ng/µL. Three microlitres of trypsin solution was added
to 10 µL of 293-amidase 150 µg/mL for digestion. Ten microlitres of 0.5 mM ammonium bicarbonate
was added and the solution digested in a heating block at 37 ◦C for 3.5 h. Mass spectrometry was
performed on the digested sample with an Axima TOF2 MALDI-TOF mass spectrometer (Shimadzu
Biotech, Manchester, UK). A 0.5 µL aliquot of matrix solution (α-cyano 4-hydroxy cinnamic acid,
10 mg/mL in 50% acetonitrile-0.1% (v/v) trifluoroacetic acid) was deposited onto the target and left
for 5 s before being removed. The residual solution was allowed to air-dry and 0.5 µL of the sample
solution was deposited onto the pre-coated sample spot. A 0.5 µL aliquot of matrix solution was added
to the deposited sample and allowed to air dry. The sample was subsequently analysed in positive-ion
reflectron mode. Protein identification was carried out via peptide mass fingerprinting (PMF) using
the Mascot search engine (http://www.matrixscience.com). The monoisotopic, positive ion data +/−
0.25 Da were searched using the following parameters: NCBInr database or Swiss Prot, taxonomy all
entries, trypsin digest with one missed cleavage.
2.6. Determination of the Activity of 293-Amidase against Live Cells of L. monocytogenes
Listeria monocytogenes 473, the strain used to propagate vB_LmoS_293, was used to test the lytic
activity of 293-amidase against live cells. For this purpose, the Clinical and Laboratory Standards
Institute (CLSI) protocol for antimicrobial dilution and disk susceptibility test protocol was used [37].
Briefly, L. monocytogenes 473 was grown in BHI broth at 37 ◦C for 16 h, the cells were harvested by
centrifugation, resuspended in sterile saline solution to a concentration of 0.5 McFarland standard,
and stored at −20 ◦C. A sterile cotton swab was used to spread the bacterial solution on the surface
of a BHI agar plate and disks for susceptibility testing (Oxoid Ltd., Basingstoke, UK) impregnated
with 293-amidase at the concentrations of 150, 100, 50, 25, 12.5, and 6.25 µg/mL were applied on
its surface. Lysozyme (20 mg/mL, Sigma, Arklow, Ireland) was used as positive control and sterile
phosphate buffer as negative control. The plates were incubated at 37 ◦C for 16 h and checked for
zones of inhibition.
2.7. Determination of 293-Amidase Muralytic Activity at Different Concentrations
To determine the muralytic activity, the 293-amidase was tested against L. monocytogenes 473, the
strain used to propagate the phage vB_LmoS_293. For the preparation of cells, L. monocytogenes 473
was grown 16 h in 100 mL of BHI broth and the cells were subsequently autoclaved at 121 ◦C for 15 min
(Astell Scientific, UK). The cells were harvested by centrifugation at 2000× g for 15 min, washed with
10 mL sterile water and aliquots frozen until required. The LB agar plates were overlaid with 5 mL
of LB top agar (0.7% agar) containing 1 g of L. monocytogenes 473 autoclaved cells. To determine the
muralytic activity, 10 µL of 293-amidase at increasing concentrations (5 µg/mL, 10 µg/mL, 20 µg/mL,
40 µg/mL, 75 µg/mL and 150 µg/mL) was spotted on a lawn of L. monocytogenes 473, dried in a laminar
flow cabinet, incubated at 37 ◦C and examined every 30 min for the presence of lysis.
The muralytic activity was determined in parallel in microtiter plates (Corning Inc., Kennebunk,
ME, USA). The autoclaved L. monocytogenes 473 cells were resuspended in sterile phosphate buffer
(NaH2PO4 5 mM, Na2HPO4 30 mM, NaCl 300 mM) to an OD620 of 1.0. A volume of 100 µL of
the cell suspension was aliquoted onto a microtiter plate well. The muralytic activity was tested as
follows: 100 µL of purified 293-amidase was added to the cells to a final concentration of 5 µg/mL,
10 µg/mL, 20 µg/mL, 40 µg/mL, and 75 µg/mL, respectively, and the reduction in turbidity at OD620
was recorded with a microplate reader (Synergy HT, Biotek Instruments, USA) at the time 0, 20, 45, 75,
105 min. The data were normalized with the controls with the equation: ((ODControl − OD293-amidase) ×
100/ODinitial) and the percentage of reduction was shown on scatter plots.
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2.8. Influence of Temperature on 293-Amidase Activity
To check the optimal temperature for activity, 1 µg of 293-amidase was spotted on a lawn of
L. monocytogenes 473, prepared as described previously, incubated at 25 ◦C, 37 ◦C and 50 ◦C and
examined every 30 min for lysis. Additionally, in microtiter plates, 100µL of autoclaved L. monocytogenes
473 cells, resuspended in phosphate buffer to an OD620 of 1.0 was added to 100 µL of 293-amidase at a
final concentration of 40 µg/mL and incubated at 25 ◦C, 37 ◦C and 50 ◦C. As negative control, 100 µL of
autoclaved L. monocytogenes 473 cells, resuspended in phosphate buffer to an OD620 of 1.0 was added
to 100 µL of phosphate buffer. The reduction in turbidity was recorded with a microplate reader at the
times 0, 30, 90, 180 min and 24 h. The 293-amidase reduction were normalized as described before and
shown on scatter plots.
2.9. Specificity of 293-Amidase
To assess the lytic activity against different bacterial strains, overnight (16 h) cultures in BHI were
prepared for each of the strains listed in Table 1. The cultures were autoclaved and the pellets were
resuspended as described previously. The LB plates were overlaid with 5 mL of LB top-agar 0.7%,
containing 1 mL of each autoclaved strain, spotted with 1 µg of 293-amidase and incubated at 37 ◦C,
checking every 30 min for the presence of lysis. The appearance of a clearing zone was considered a
confirmation of lytic activity against the strains tested.
The specificity of 293-amidase was tested also as turbidity reduction at OD620. The autoclaved
strains listed in Table 1 were resuspended in phosphate buffer to an OD620 of 1.0. In a microtiter
plate, 100 µL of resuspended cells was added to 100 µL of 293-amidase at a final concentration of
40 µg/mL. The reduction in turbidity at OD620 was measured with a microplate reader every 10 min at
an incubation temperature of 37 ◦C.
2.10. Influence of pH on 293-Amidase Activity
Buffers at pH 4 (Na-citrate 20 mM, pH 4), pH 8 (Tris-HCl 20 mM, pH 8) and pH 10 (boric acid
20 mM, pH 10) were used to resuspend autoclaved cells of L. monocytogenes strain 473 to assess the
influence of pH on the amidase activity. The cells were resuspended to an OD620 of 1.0 and, in a
microtiter plate, 100 µL of cell suspension was mixed with 100 µL of 293-amidase at a final concentration
of 40 µg/mL and the reduction in turbidity at OD620 was recorded every 10 min by a microplate reader
with incubation temperature of 37 ◦C.
2.11. Efficacy of 293-Amidase against L. monocytogenes Biofilm
The 293-amidase antibiofilm activity was tested on polystyrene microtiter plates and stainless-steel
coupons. To assess the efficacy of the amidase to prevent adhesion of L. monocytogenes to an abiotic
surface, 10 µL of an overnight (16 h) culture of L. monocytogenes 473 was added to 90 µL of BHI broth
in a microtiter plate well. In the control wells, 100 µL of phosphate buffer was added, while in the
treatment wells, 100 µL of 293-amidase at a final concentration of 75 µg/mL was added to the cell
suspensions. The microplate was incubated for 5 days at 20 ◦C and the biofilms were stained with
crystal violet [1]. The absorbance at 595 nm was recorded with a microplate reader.
To test the efficacy of the 293-amidase on L. monocytogenes biofilm removal, 20 µL of an overnight
(16 h) culture was added to 180µL of BHI broth in a microtiter plate well. After four days of incubation at
20 ◦C, the wells were washed with phosphate buffer saline (PBS, Sigma, Ireland) to remove unattached
cells and 100 µL of phosphate buffer was added to the control wells, while 100 µL of 293-amidase at a
final concentration of 75 µg/mL was added to the treatment wells. After 24 h of incubation at 20 ◦C, the
microplate was stained with crystal violet and the results recorded as stated previously.
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2.12. Fluorescence Microscopy on Stainless-Steel Coupons
Stainless-steel (ss) coupons (10 by 15 mm, type AISI-304, no. 2b, finish, 3 mm thick) were prepared
as described in Reference [1]. Briefly, the coupons were treated with acetone, washed with a detergent,
rinsed thoroughly with water and autoclaved at 121 ◦C for 15 min. Each coupon was placed in a well
of a square Petri dish with 25 compartments (Thermo Fisher Scientific, USA) and tested for the efficacy
of the 293-amidase to prevent adhesion and for biofilm removal. To test the anti-adhesion activity, to
each well containing a coupon, 500 µL of BHI broth plus 10 µL of a 16 h culture of L. monocytogenes 473
were added. To the control and the treatment, 500 µL of phosphate buffer or 75 µg of 293-amidase in
500 µL phosphate buffer were added, respectively. After 5 days of incubation at 20 ◦C, the coupons
were washed with PBS to remove unattached cells and stained with live/dead fluorescent dye (Thermo
Fisher Scientific, Waltham, MA, USA) containing Propidium Iodide (excitation/emission 535/617 nm)
and Syto9 (excitation/emission 485/498 nm), following the manufacturer’s instructions. Biofilms were
visualised with a Leica DMi8 fluorescent microscope and images processed with the LAS X software
(Leica, Wetzlar, Germany).
To test the 293-amidase biofilm removal activity, 1 mL of BHI with 10 µL of a 16 h culture of
L. monocytogenes 473 was added to each well containing a coupon. Biofilms were grown for 4 days
at 20 ◦C and then the coupons were washed with PBS and 500 µL of phosphate buffer or 75 µg of
293-amidase in 500 µL phosphate buffer were added respectively to the control and the treatment.
After 24 h of incubation at 20 ◦C, the coupons were washed again with PBS, stained with live/dead
fluorescent dye and observed as described previously.
2.13. Statistical Analysis
Turbidity reduction assays were performed in independent triplicates and the data obtained were
analysed with the Student’s t-test.
3. Results
3.1. Cloning, Expression and Purification of the 293-Amidase
Bioinformatic analysis of the phage vB_LmoS_293 genome suggested that nucleotides 19966–20916
(951 bp) of ORF 25 encoded the 316 amino acid endolysin and that the protein belongs to the
N-acetylmuramoyl-L-alanine amidase CwlA family (COG5632), with residues 23–157 belonging to
the amidase 2 family (pfam01510). Residues 179–316 had a sequence identity of 78% with residues
189–326 of Listeria endolysin PlyPsa (PDB code 1XOV), corresponding to the cell wall binding domain
of this enzyme, with no associated catalytic activity [38]. A gene fragment encoding residues 1 to
178 of the putative vB_LmoS_293 phage endolysin, i.e., the predicted amidase domain plus flanking
N-terminal and C-terminal residues, was PCR-amplified from the genome of vB_LmoS_293 and cloned
into the expression vector pCri-8a, using the NcoI and HindIII restriction sites [36]. The DNA sequence
analysis of the expression plasmid confirmed the correct insertion, although a single silent point
mutation was observed (Supplementary Materials Figure S1B). The predicted length of the expressed
protein was 219 amino acids (including the N-terminal His6 purification tag), with a predicted mass
of 25 kDa and an isoelectric point of 9.3. In Supplementary Materials Figure S2, an SDS-PAGE gel
shows the over-expression of a protein between 25 kDa and 35 kDa. This protein was confirmed as the
293-amidase by peptide mass fingerprinting (Supplementary Materials Figure S3). The concentration
of the purified 293-amidase was 150 µg/mL.
3.2. Activity of 293-Amidase against L. monocytogenes
The disk diffusion assay showed no inhibition against any of the live strains by any of the
293-amidase dilutions tested, while inhibition was shown by the lysozyme used as positive control.
Viruses 2019, 11, 722 8 of 14
3.3. Determination of Muralytic Activity of 293-Amidase
The spot-on-lawn and microtiter assays performed on autoclaved L. monocytogenes 473 cells
showed muralytic activity starting from a concentration of 10 µg/mL. In the microtiter plate assays,
this concentration gave a 10% reduction in 105 min incubation (Figure 1, p < 0.05), while a 34.5% and
35.7% reduction in autoclaved L. monocytogenes 473 in 105 min incubation was observed at 40 µg/mL
and 75 µg/mL, respectively (p < 0.05).
Figure 1. Dose-dependent muralytic activity of the 293-amidase against autoclaved L. monocytogenes
473 cells. Lytic activity (assays in microtiter plates) is represented as the percentage of turbidity
reduction operated by the 293-amidase at different concentrations. Different colours are different
concentrations: blue, 10 µg/mL; red, 20 µg/mL; green, 40 µg/mL; purple, 75 µg/mL. Each data point is
the average of triplicates and the standard deviations are indicated as error bars.
3.4. Influence of pH and Temperature on Activity of 293-Amidase
The 293-amidase showed activity at different pH conditions. There was no significant difference
(p > 0.05) in the activity of the 293-amidase at the pH values tested: 38%, 41% and 45% at pH values 4,
8 and 10, respectively.
The temperature influenced the activity of the 293-amidase (Figure 2), showing 40% of turbidity
reduction in microtiter plates after 150 min of incubation, and visible lysis on a lawn of L. monocytogenes
473 after 30 min of incubation at 37 ◦C. By contrast, at 25 ◦C and 50 ◦C, the turbidity reduction after
150 min of incubation was 8.9% and 8.1%, respectively, and on the spot-on-lawn assay, the lysis was
shown only after 3 h of incubation.
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Figure 2. Influence of temperature on the lytic activity of the 293-amidase (40 µg/mL) against autoclaved
L. monocytogenes 473. Lytic activity datasets are represented as in Figure 1. Different line colours are
different temperatures: blue, 25 ◦C; red, 37 ◦C; green, 50 ◦C.
3.5. Specificity of 293-Amidase
Of the strains tested, described in Table 1, the 293-amidase showed muralytic activity only in
the presence of L. monocytogenes 473 (serotype 4b) and 3099 (serogroup 1/2b-3b-7), with a statistically
significant difference between the controls and treatments (p < 0.05, Figure 3).
Figure 3. Muralytic activity of the 293-amidase domain (40 µg/mL) against L. monocytogenes strains 473
(red) and 3099 (blue). Lytic activity datasets are represented as in Figure 1.
3.6. Biofilm Inhibition and Removal
The tests performed on biofilm inhibition and removal are summarised in Figure 4. Incubation
of 75 µg of 293-amidase with L. monocytogenes 473 at 20 ◦C resulted in a 78% reduction (p < 0.0001)
in the formation of biofilm on polystyrene microplates tested after 5 days of incubation (Figure 4A).
The 293-amidase applied to a 4 day old biofilm resulted in a 25% reduction on the pre-formed biofilm
(p < 0.05, Figure 4B).
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Figure 4. Biofilm prevention (A) and biofilm removal ability (B) of the 293-amidase (75 µg/mL) against
L. monocytogenes 473 in microtiter plates assays. The blue bars represent the controls (untreated biofilm)
and the red bars the treatments. Values are the average of triplicates and the standard deviation is
represented as error bars. The p-values are shown below the horizontal axes. (C–E) The images obtained
from the stainless-steel coupons assays. (C) L. monocytogenes 473 biofilm after 4 days of incubation at
20 ◦C. (D) Co-inoculation of L. monocytogenes 473 and 293-amidase (150 µg/mL). (E) The application of
293-amidase (150 µg/mL) on a 4 day old biofilm. The red-stained cells were damaged or dead, while
the green stained cells were alive. The scale bars at the bottom-right in (C–E) are 10 µm.
On stainless steel coupons, the 293-amidase inhibited the formation of a biofilm, while no evidence
of removal was observed when the protein was applied on a 4 day old biofilm (Figure 4C–E). Live and
damaged cells, stained with the Live/Dead fluorescent dye, were observed in both the controls and
treated biofilms.
4. Discussion
In food safety, the use of phage-derived proteins as antimicrobials and for biofilm removal is
currently being investigated [19,33]. Using only the catalytic domains rather than the full-length
endolysin can facilitate the production of the recombinant protein, by increasing their stability and
solubility and, in some cases, can improve their activity [39,40]. The results described in this work
have shown that the 293-amidase is able to degrade the peptidoglycan of autoclaved L. monocytogenes
473 cells, starting from a concentration of 10 µg/mL. However, on live cells, no inhibition was shown.
It is common practice to freeze the substrate cells before use, to make them susceptible to phage
enzymes, as described in previous studies (e.g., [41]), but the damage inflicted by the 293-amidase to
live cell walls is apparently not sufficient to overcome their ability to recover. The results shown in this
study, although showing no lethal effect on live cells under the experimental conditions attempted,
highlighted the possibility of using temperate bacteriophage DNA to produce recombinant endolysins
or, in this case, single domains, for biocontrol purposes.
For this reason, the 293-amidase was tested against autoclaved cells. The specificity range of
293-amidase is broader than that of the phage itself, because of the amidase activity recorded against a
1/2b-3b-7 strain. Further characterisation of the 293-amidase showed a reduction in turbidity at all the
pH values tested, but there was no significant difference in the values tested between pH 4 and 8. It is
possible that the different buffer components used influenced this, but as there was no difference in the
activity at the pH values tested, further studies were not undertaken. In previous studies, improved
activity was observed at pH 8–9 by other endolysins [42,43].
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The antimicrobial activity of the 293-amidase showed the potential for preventing biofilm formation.
When 293-amidase was co-inoculated with L. monocytogenes 473, biofilm formation was inhibited, both
in polystyrene microtiter plates and on stainless-steel coupons. In contrast, when applied to a four-day
old biofilm, the 293-amidase showed a reduction of 25% in polystyrene plates, while on stainless-steel
coupons no differences were observed between the control and treatment. Possibly, the differences were
minimal and could not be visualised, or the biofilm formed on stainless-steel coupons was thicker than
the biofilm formed on polystyrene plates and was less affected by the application of the 293-amidase,
although high-binding microwell plates were used in this study. This would contradict past studies,
where differences in L. monocytogenes biofilm formation ability related to the surfaces tested were
shown, with a stronger biofilm formed on polystyrene surfaces than the one formed on stainless-steel
coupons [44,45]. It is likely that the damage induced by the 293-amidase to the peptidoglycan of the
bacterial cells prevents adhesion on abiotic surfaces. In this way, the formation of the biofilm, both
on polystyrene microtiter plates and stainless-steel coupons, was inhibited. Prevention of biofilm
formation would lead to many benefits, in particular to the food production industry. The choice of the
abiotic surfaces used in this study for biofilm formation was driven by the necessity of having general
screening data on 293-amidase potential biofilm inhibition, data produced by the polystyrene microtiter
plates, and the necessity of testing a material commonly used in the food production environment.
Stainless steel is, indeed, commonly used, for example, for tables, platforms and cutters in many
branches of food production [45]. To date, anti-listerial activity of endolysins has been mainly focused
on in vitro experiments on planktonic cells or only a few food matrices [46]. Only the endolysin
PlyLM, identified by Simmons et al. (2012) [47] in the genome of a L. monocytogenes 4b strain, has been
previously tested against L. monocytogenes biofilms [47]. In that case, a monolayer biofilm was grown
for 24 h at 37 ◦C and PlyLM reduced the biofilm by 20%, while completely removing the biofilm when
combined with a protease. Further investigations might be required to assess if the same activity is
registered at lower temperatures, such as 20 ◦C, as tested in this study, which more accurately reflects
the food production environment.
The antibiofilm activity observed in this study highlights a potential application of 293-amidase
in the food production industry, where a major problem is represented by the cross contamination
of L. monocytogenes from the processing environment to the final product [48–51]. Furthermore, the
association between biofilm formation and sanitiser resistance in L. monocytogenes [52] highlights the
importance of the anti-biofilm properties shown by the purified 293-amidase. However, optimisation
of the production process is required. It needs to be highlighted that microtiter plate assays have some
limitations, especially the possible evaporation of the buffer, with condensation on the lid, after long
periods of incubation, which increases the standard deviation of the measurements. Furthermore,
the starting cell suspension was set at 1 OD620 with a standard spectrophotometer cuvette, but after
the application of cell suspension and treatments to the microtiter plate wells, the starting OD620
was between 0.2 and 0.4, probably due to the different measurement system used by the standard
spectrophotometer (with horizontal light path) and the microtiter plate reader (with vertical light path).
The combination of lysins and other treatments, in some cases, has shown to improve their
effectiveness in pathogen control in the food production by improving hurdle technology, for example
the combination of PlyP100 with nisin in fresh cheese [28]. In that study, nisin alone had a poor
anti-listerial effect on queso fresco cheese, while PlyP100 had a stronger anti-listerial activity. It was
demonstrated that the combination of the two treatments improved the L. monocytogenes removal from
queso fresco, with occurrence below the detection limit after 4 weeks of incubation [28].
Studies on the application of endolysins in the food production environment are still limited.
The 293-amidase potential for biofilm prevention on abiotic surfaces highlights the need of further
studies to show the effect of this novel treatment in vivo.
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5. Conclusions
In this study, the 293-amidase showed anti-listerial activity on autoclaved cells and this activity
was characterised for specificity, pH, temperature, and concentration. The results on biofilms grown
on microtiter plates showed a potential preventive activity against L. monocytogenes biofilm and a
reduction in a four-day old biofilm. The 293-amidase was not active against live cells; however, its
muralytic activity can still be considered for prevention of L. monocytogenes biofilm formation. Further
studies are required to optimise the process of 293-amidase production and its possible application in
the food processing environment, where tools to prevent biofilm formation are needed.
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